Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “the Efficacy and Safety”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT04229030
What this trial is testing

RZL-012 for Dercum's Disease Lipomas

Who this might be right for
Dercum's Disease Lipomas
Raziel Therapeutics Ltd. 38
Early research (Phase 1)Ended earlyNCT06406400
What this trial is testing

Drug-Drug Interaction and Safety of AZD4041 Study (Part 1) and Efficacy, Safety, Pharmacokinetics and Pharmacodynamics of AZD4041 Study in Opioid Use Disorder (Part 2).

Who this might be right for
Opioid Use Disorder
AstraZeneca 15
Testing effectiveness (Phase 2)Study completedNCT03424707
What this trial is testing

Evaluate the Efficacy and Safety of Fixed Dose Combination of DW340 in Patients With Acute Low Back Pain

Who this might be right for
Acute Low Back Pain
Daewon Pharmaceutical Co., Ltd. 45
Not applicableStudy completedNCT01481792
What this trial is testing

Efficacy and Safety of ReLEx Smile for Laser Correction of Myopia

Who this might be right for
Myopia
University of Aarhus 125
Large-scale testing (Phase 3)Study completedNCT00385307
What this trial is testing

Efficacy and Safety of SR58611A in Patients With Major Depressive Disorder (SIRIUS)

Who this might be right for
Major Depressive Disorder
Sanofi 680
Post-approval studies (Phase 4)Study completedNCT00796692
What this trial is testing

Nadroparin for the Initial Treatment of Pulmonary Thromboembolism

Who this might be right for
Pulmonary EmbolismThromboembolismVascular Diseases+1 more
Beijing Chao Yang Hospital 274
Testing effectiveness (Phase 2)Looking for participantsNCT06887192
What this trial is testing

Assess the Efficacy and Safety of ML-007C-MA for the Treatment of Alzheimer's Disease Psychosis

Who this might be right for
Psychosis Associated With Alzheimer's Disease
MapLight Therapeutics 300
Large-scale testing (Phase 3)Study completedNCT04976192
What this trial is testing

Study to Compare Efficacy and Safety of TEV-45779 With XOLAIR (Omalizumab) in Adults With Chronic Idiopathic Urticaria

Who this might be right for
Chronic Urticaria
Teva Pharmaceuticals USA 608
Post-approval studies (Phase 4)Study completedNCT03440736
What this trial is testing

Comparison of Secukinumab 300 mg Combined With a Lifestyle Intervention to Secukinumab Alone for the Treatment of Moderate to Severe Psoriasis Patients With Concomitant Metabolic Syndrome

Who this might be right for
PsoriasisMetabolic Syndrome
Novartis Pharmaceuticals 781
Early research (Phase 1)Not Yet RecruitingNCT05094011
What this trial is testing

Evaluating Safety, Tolerability, and Efficacy of Autologous MitoCell Transplantation in Subjects With Idiopathic Parkinson's Disease

Who this might be right for
Idiopathic Parkinson's Disease
Taiwan Mitochondrion Applied Technology Co., Ltd. 9
Not applicableStudy completedNCT04009057
What this trial is testing

Effectiveness, Safety, Adherence, and Health-related Quality of Life in HIV-1 Infected Adults Receiving Bictegravir/ Emtricitabine/Tenofovir Alafenamide (B/F/TAF)

Who this might be right for
HIV-1-infection
Gilead Sciences 143
Testing effectiveness (Phase 2)Study completedNCT04643457
What this trial is testing

Test the Safety, Pharmacokinetics, and Efficacy of UCB9741 in Healthy Study Participants and in Study Participants With Atopic Dermatitis

Who this might be right for
Atopic Dermatitis
UCB Biopharma SRL 107
Large-scale testing (Phase 3)Ended earlyNCT04636801
What this trial is testing

A 52-week, Placebo-controlled Study to Evaluate the Efficacy and Safety of 2 Doses of CHF6001 DPI (Tanimilast), as add-on to Maintenance Triple Therapy in Subjects With COPD and Chronic Bronchitis (PILASTER)

Who this might be right for
Chronic Obstructive Pulmonary Disease
Chiesi Farmaceutici S.p.A. 4,710
Post-approval studies (Phase 4)Study completedNCT03700801
What this trial is testing

Study of Efficacy, Weight Control, and Safety in Newly-diagnosed Type 2 Diabetes With Different Antidiabetic Therapy

Who this might be right for
Type 2 Diabetes Mellitus
Zhujiang Hospital 130
Large-scale testing (Phase 3)Study completedNCT01313312
What this trial is testing

Dysport® Adult Upper Limb Spasticity Extension Study

Who this might be right for
Nervous System Disorders
Ipsen 258
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06487000
What this trial is testing

Determine the Dose-dependent Efficacy and Safety of EC-18 in Patients With Moderate to Severe Atopic Dermatitis

Who this might be right for
Atopic Dermatitis
Enzychem Lifesciences Corporation 150
Not applicableNot Yet RecruitingNCT07492992
What this trial is testing

HOME-AHCL: Home-Based Implementation of an Advanced Hybrid Closed-Loop System With Telemonitoring in Type 1 Diabetes

Who this might be right for
Diabetes Mellitus Type 1
Air Liquide Healthcare Spain 80
Not applicableStudy completedNCT01065792
What this trial is testing

Stocrin Re-examination Study (0831-028)

Who this might be right for
HIV Infection
Merck Sharp & Dohme LLC 728
Large-scale testing (Phase 3)Not Yet RecruitingNCT07174492
What this trial is testing

Efficacy and Safety of Masitinib in Combination With SoC Versus Placebo in the Treatment of ALS Patients

Who this might be right for
Amyotrophic Lateral Sclerosis (ALS)
AB Science 412
Large-scale testing (Phase 3)Not Yet RecruitingNCT07113392
What this trial is testing

Evaluate the Safety, Efficacy and Pharmacokinetics of Suraxavir Marboxil for Suspension

Who this might be right for
Influenza
Jiangxi Kvvit Pharmaceutical Co., Ltd. 144
Next Page